The DOI matches its Crossref record; 102 of the 102 references it cites were found in a registry or an index.
The Pathogenesis of Lupus Nephritis
Open accessAbstract
Lupus nephritis is an immune complex GN that develops as a frequent complication of SLE. The pathogenesis of lupus nephritis involves a variety of pathogenic mechanisms. The extrarenal etiology of systemic lupus is based on multiple combinations of genetic variants that compromise those mechanisms normally assuring immune tolerance to nuclear autoantigens. This loss of tolerance becomes clinically detectable by the presence of antinuclear antibodies. In addition, nucleic acids released from netting or apoptotic neutrophils activate innate and adaptive immunity via viral nucleic acid-specific Toll-like receptors. Therefore, many clinical manifestations of systemic lupus resemble those of viral infection. In lupus, endogenous nuclear particles trigger IFN-α signaling just like viral particles during viral infection. As such, dendritic cells, T helper cells, B cells, and plasma cells all contribute to the aberrant polyclonal autoimmunity. The intrarenal etiology of lupus nephritis involves antibody binding to multiple intrarenal autoantigens rather than the deposition of circulating immune complexes. Tertiary lymphoid tissue formation and local antibody production add to intrarenal complement activation as renal immunopathology progresses. Here we provide an update on the pathogenic mechanisms that lead to lupus nephritis and provide the rationale for the latest and novel treatment strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2016) · Diagnostic Imaging: Brain · doi:10.1016/b978-0-323-37754-6.50094-4 · Cited by 3,990
Tsokos, G. C. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1100359 · Cited by 2,736
Navarra, S. V., Guzmán, R. M., Gallacher, A. E., Hall, S., Levy, R. A., Jimenez, R. E., Li, E. K.-M., Thomas, M., Kim, H.-Y., León, M. G., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(10)61354-2 · Cited by 2,074
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette, B. C., Shlomchik, M. J., & Marshak-Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,900
The classification of glomerulonephritis in systemic lupus erythematosus revisited
Weening, J. J., ON Behalf of the International Society of Nephrology and Renal Pathology Society Working Group on the Classification Oflupus Nephritis, D'agati, V. D., Schwartz, M. M., Seshan, S. V., Alpers, C. E., Appel, G. B., Balow, J. E., Bruijn, J. A. N. A., Cook, T., et al. (2004) · Kidney International · doi:10.1111/j.1523-1755.2004.00443.x · Cited by 1,652
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
Hakkim, A., Fürnrohr, B. G., Amann, K., Laube, B., Abed, U. A., Brinkmann, V., Herrmann, M., Voll, R. E., & Zychlinsky, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909927107 · Cited by 1,469
Hahn, B. H., McMahon, M. A., Wilkinson, A., Wallace, W. D., Daikh, D. I., FitzGerald, J. D., Karpouzas, G. A., Merrill, J. T., Wallace, D. J., Yazdany, J., et al. (2012) · Arthritis Care & Research · doi:10.1002/acr.21664 · Cited by 1,463
Rovin, B. H., Furie, R., Latinis, K., Looney, R. J., Fervenza, F. C., Sanchez‐Guerrero, J., Maciuca, R., Zhang, D., Garg, J. P., Brunetta, P., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34359 · Cited by 1,461
Merrill, J. T., Neuwelt, C. M., Wallace, D. J., Shanahan, J. C., Latinis, K. M., Oates, J. C., Utset, T. O., Gordon, C., Isenberg, D. A., Hsieh, H., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27233 · Cited by 1,409
Garcia-Romo, G. S., Caielli, S., Vega, B., Connolly, J., Allantaz, F., Xu, Z., Punaro, M., Baisch, J., Guiducci, C., Coffman, R. L., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001201 · Cited by 1,383
Lande, R., Ganguly, D., Facchinetti, V., Frasca, L., Conrad, C., Gregorio, J., Meller, S., Chamilos, G., Sebasigari, R., Riccieri, V., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001180 · Cited by 1,303
Renal-Limited “Lupus-Like” Nephritis: How Much of a Lupus
Maziad, A. S. A., Torrealba, J., Seikaly, M. G., Hassler, J. R., & Hendricks, A. R. (2017) · Case Reports in Nephrology and Dialysis · doi:10.1159/000475493 · Cited by 1,299
Villanueva, E., Yalavarthi, S., Berthier, C. C., Hodgin, J. B., Khandpur, R., Lin, A. M., Rubin, C. J., Zhao, W., Olsen, S. H., Klinker, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100450 · Cited by 1,241
TYPE I INTERFERONS (α/β) IN IMMUNITY AND AUTOIMMUNITY
Theofilopoulos, A. N., Baccala, R., Beutler, B., & Kono, D. H. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115843 · Cited by 1,185
mRNA is an endogenous ligand for toll-like receptor 3
Karikó, K., Ni, H., Capodici, J., Lamphier, M., & Weissman, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310175200 · Cited by 1,062
Lau, C. M., Broughton, C., Tabor, A. S., Akira, S., Flavell, R. A., Mamula, M. J., Christensen, S. R., Shlomchik, M. J., Viglianti, G. A., Rifkin, I. R., et al. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050630 · Cited by 812
Chan, O. T. M., Hannum, L. G., Haberman, A. M., Madaio, M. P., & Shlomchik, M. J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.10.1639 · Cited by 698
The role of defective clearance of apoptotic cells in systemic autoimmunity
Muñoz, L. E., Lauber, K., Schiller, M., Manfredi, A. A., & Herrmann, M. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.46 · Cited by 627
Neubert, K., Meister, S., Moser, K., Weisel, F., Maseda, D., Amann, K., Wiethe, C., Winkler, T. H., Kalden, J. R., Manz, R. A., et al. (2008) · Nature Medicine · doi:10.1038/nm1763 · Cited by 584
Richardson, B., Scheinbart, L., Strahler, J., Gross, L., Hanash, S., & Johnson, M. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780331109 · Cited by 562
Houssiau, F. A., Vasconcelos, C., D'Cruz, D., Sebastiani, G. D., de Ramon Garrido, E., Danieli, M. G., Abramovicz, D., Blockmans, D., Cauli, A., Direskeneli, H., et al. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2008.102533 · Cited by 542
Hydroxychloroquine in lupus pregnancy
Clowse, M. E. B., Magder, L., Witter, F., & Petri, M. (2006) · Arthritis & Rheumatism · doi:10.1002/art.22159 · Cited by 529
Taming lupus-a new understanding of pathogenesis is leading to clinical advances
Liu, Z., & Davidson, A. (2012) · Nature Medicine · doi:10.1038/nm.2752 · Cited by 433
Multistep Pathogenesis of Autoimmune Disease
Goodnow, C. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.033 · Cited by 427
Hydralazine and procainamide inhibit T cell DNA methylation and induce autoreactivity.
Cornacchia, E., Golbus, J., Maybaum, J., Strahler, J., Hanash, S., & Richardson, B. (1988) · The Journal of Immunology · doi:10.4049/jimmunol.140.7.2197 · Cited by 420
Regulation of leukocyte recruitment by the long pentraxin PTX3
Deban, L., Russo, R. C., Sironi, M., Moalli, F., Scanziani, M., Zambelli, V., Cuccovillo, I., Bastone, A., Gobbi, M., Valentino, S., et al. (2010) · Nature Immunology · doi:10.1038/ni.1854 · Cited by 418
Manzi, S., Sánchez-Guerrero, J., Merrill, J. T., Furie, R., Gladman, D., Navarra, S. V., Ginzler, E. M., D'Cruz, D. P., Doria, A., Cooper, S., et al. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2011-200831 · Cited by 411
Long-lived autoreactive plasma cells drive persistent autoimmune inflammation
Hiepe, F., Dörner, T., Hauser, A. E., Hoyer, B. F., Mei, H., & Radbruch, A. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.1 · Cited by 389
TLR recognition of self nucleic acids hampers glucocorticoid activity in lupus
Guiducci, C., Gong, M., Xu, Z., Gill, M., Chaussabel, D., Meeker, T., Chan, J. H., Wright, T., Punaro, M., Bolland, S., et al. (2010) · Nature · doi:10.1038/nature09102 · Cited by 380
Merrill, J. T., Burgos‐Vargas, R., Westhovens, R., Chalmers, A., D'Cruz, D., Wallace, D. J., Bae, S. C., Sigal, L., Becker, J. ‐., Kelly, S., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27601 · Cited by 376
Chang, A., Henderson, S. G., Brandt, D., Liu, N., Guttikonda, R., Hsieh, C., Kaverina, N., Utset, T. O., Meehan, S. M., Quigg, R. J., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1001983 · Cited by 360
Endogenous antigen tunes the responsiveness of naive B cells but not T cells
Zikherman, J., Parameswaran, R., & Weiss, A. (2012) · Nature · doi:10.1038/nature11311 · Cited by 324
Pons‐Estel, G. J., Alarcón, G. S., McGwin, G., Danila, M. I., Zhang, J., Bastian, H. M., Reveille, J. D., & Vilá, L. M. (2009) · Arthritis Care & Research · doi:10.1002/art.24538 · Cited by 306
Barrat, F. J., Meeker, T., Chan, J. H., Guiducci, C., & Coffman, R. L. (2007) · European Journal of Immunology · doi:10.1002/eji.200737815 · Cited by 284
The central and multiple roles of B cells in lupus pathogenesis
Chan, O. T. M., Madaio, M. R., Shlomchik, M. J., Chan, O. I. M., Madaio, M. P., & Shlomchik, M. J. (1999) · Immunological Reviews · doi:10.1111/j.1600-065x.1999.tb01310.x · Cited by 281
Savarese, E., Chae, O.-W., Trowitzsch, S., Weber, G., Kastner, B., Akira, S., Wagner, H., Schmid, R. M., Bauer, S., & Krug, A. (2006) · Blood · doi:10.1182/blood-2005-07-2650 · Cited by 271
Yu, F., Wu, L.-H., Tan, Y., Li, L.-H., Wang, C.-L., Wang, W.-K., Qu, Z., Chen, M.-H., Gao, J.-J., Li, Z.-Y., et al. (2010) · Kidney International · doi:10.1038/ki.2010.13 · Cited by 249
Ichikawa, H. T., Conley, T., Muchamuel, T., Jiang, J., Lee, S., Owen, T., Barnard, J., Nevarez, S., Goldman, B. I., Kirk, C. J., et al. (2012) · Arthritis & Rheumatism · doi:10.1002/art.33333 · Cited by 244
Merrill, J. T., Wallace, D. J., Petri, M., Kirou, K. A., Yao, Y., White, W. I., Robbie, G., Levin, R., Berney, S. M., Chindalore, V., et al. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.144485 · Cited by 231
Pawar, R. D., Ramanjaneyulu, A., Kulkarni, O. P., Lech, M., Segerer, S., & Anders, H.-J. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006101162 · Cited by 227
Self-citationProgesterone and autoimmune disease
Hughes, G. C. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.12.003 · Cited by 225
Smeets, B., Kuppe, C., Sicking, E.-M., Fuss, A., Jirak, P., van Kuppevelt, T. H., Endlich, K., Wetzels, J. F. M., Gröne, H.-J., Floege, J., et al. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010090970 · Cited by 224
Activation of toll‐like receptor‐9 induces progression of renal disease in MRL‐Fas(lpr) mice
Anders, H., Vielhauer, V., Eis, V., Linde, Y., Kretzler, M., Perez de Lema, G., Strutz, F., Bauer, S., Rutz, M., Wagner, H., et al. (2004) · The FASEB Journal · doi:10.1096/fj.03-0646fje · Cited by 209
Self-citationDevelopment of TLR inhibitors for the treatment of autoimmune diseases
Barrat, F. J., & Coffman, R. L. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00630.x · Cited by 206
Smeets, B., Angelotti, M. L., Rizzo, P., Dijkman, H., Lazzeri, E., Mooren, F., Ballerini, L., Parente, E., Sagrinati, C., Mazzinghi, B., et al. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2009020132 · Cited by 196
Beyond the LUNAR trial. Efficacy of rituximab in refractory lupus nephritis
Weidenbusch, M., Römmele, C., Schröttle, A., & Anders, H.-J. (2013) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfs285 · Cited by 190
Self-citationSpiegelmer Inhibition of CCL2/MCP-1 Ameliorates Lupus Nephritis in MRL-(Fas)lpr Mice
Kulkarni, O., Pawar, R. D., Purschke, W., Eulberg, D., Selve, N., Buchner, K., Ninichuk, V., Segerer, S., Vielhauer, V., Klussmann, S., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006121348 · Cited by 187
Self-citationMechanisms of tissue injury in lupus nephritis
Nowling, T. K., & Gilkeson, G. S. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3528 · Cited by 184
Katsiari, C. G., Liossis, S.-N. C., & Sfikakis, P. P. (2010) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2008.11.002 · Cited by 184
Teichmann, L. L., Ols, M. L., Kashgarian, M., Reizis, B., Kaplan, D. H., & Shlomchik, M. J. (2010) · Immunity · doi:10.1016/j.immuni.2010.11.025 · Cited by 175
BAFF and selection of autoreactive B cells
Liu, Z., & Davidson, A. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.06.004 · Cited by 171
Local Renal Autoantibody Production in Lupus Nephritis
Espéli, M., Bökers, S., Giannico, G. A., Dickinson, H. A., Bardsley, V., Fogo, A. B., & Smith, K. G. C. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010050515 · Cited by 165
Caricchio, R., McPhie, L., & Cohen, P. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.11.5778 · Cited by 163
Human Lupus Inclusions and Interferon
Rich, S. A. (1981) · Science · doi:10.1126/science.6166984 · Cited by 161
Triantafyllopoulou, A., Franzke, C.-W., Seshan, S. V., Perino, G., Kalliolias, G. D., Ramanujam, M., van Rooijen, N., Davidson, A., & Ivashkiv, L. B. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914902107 · Cited by 156
Bethunaickan, R., Berthier, C. C., Ramanujam, M., Sahu, R. K., Zhang, W., Sun, Y., Böttinger, E. P., Ivashkiv, L. B., Kretzler, M., & Davidson, A. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003010 · Cited by 149
Savarese, E., Steinberg, C., Pawar, R. D., Reindl, W., Akira, S., Anders, H., & Krug, A. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23407 · Cited by 138
Self-citationIL-17-producing T cells in lupus nephritis
Apostolidis, S. A., Crispín, J. C., & Gc, T. (2011) · Lupus · doi:10.1177/0961203310389100 · Cited by 134
Complement Factor H Deficiency Accelerates Development of Lupus Nephritis
Bao, L., Haas, M., & Quigg, R. J. (2010) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010060647 · Cited by 132
Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens
Lech, M., Kulkarni, O. P., Pfeiffer, S., Savarese, E., Krug, A., Garlanda, C., Mantovani, A., & Anders, H. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20072646 · Cited by 130
Self-citationWang, Y., Ito, S., Chino, Y., Goto, D., Matsumoto, I., 村田, 秀., Tsutsumi, A., Hayashi, T., Uchida, K., Usui, J., et al. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04031.x · Cited by 122
de Lema, G. P., Maier, H., Franz, T. J., Escribese, M. M., Chilla, S., Segerer, S., Camarasa, N., Schmid, H., Banas, B., Kalaydjiev, S., et al. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005040426 · Cited by 114
Anders, H., Belemezova, E., Eis, V., Segerer, S., Vielhauer, V., de Lema, G. P., Kretzler, M., Cohen, C. D., Frink, M., Horuk, R., et al. (2004) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000130082.67775.60 · Cited by 111
Self-citationBekar, K. W., Owen, T., Dunn, R., Ichikawa, T., Wang, W., Wang, R., Barnard, J., Brady, S. P., Nevarez, S., Goldman, B., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27515 · Cited by 110
Wang, H., Cui, T., Hou, F., Ni, Z., Chen, X., Lu, F., Xu, F., Yu, X., Zhang, F. S., Zhao, X., et al. (2008) · Lupus · doi:10.1177/0961203308089408 · Cited by 103
Nephritogenic Potential of Anti-DNA Antibodies against Necrotic Nucleosomes
Mortensen, E., & Rekvig, O. P. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008010112 · Cited by 102
Fairhurst, A., Xie, C., Fu, Y., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900742 · Cited by 100
G-Rich DNA Suppresses Systemic Lupus
Patole, P. S., Zecher, D., Pawar, R. D., Gröne, H., Diaeresis]ndorff, D. S., & Anders, H. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005060658 · Cited by 96
Self-citationThe role of innate immunity in autoimmune tissue injury
Allam, R., & Anders, H. (2008) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e3283025ed4 · Cited by 92
Self-citationYung, S., & Chan, T. M. (2012) · Clinical and Developmental Immunology · doi:10.1155/2012/139365 · Cited by 91
Tojo, T., & Friou, G. J. (1968) · Science · doi:10.1126/science.161.3844.904 · Cited by 90
FcγRIIB, FcγRIIIB, and systemic lupus erythematosus
Niederer, H. A., Clatworthy, M., Willcocks, L., & Smith, K. G. C. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05132.x · Cited by 89
B-cell depletion in the treatment of lupus nephritis
Gregersen, J. W., & Jayne, D. R. W. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2012.141 · Cited by 88
Interferon-α and -β in kidney inflammation
Anders, H., Lichtnekert, J., & Allam, R. (2010) · Kidney International · doi:10.1038/ki.2010.71 · Cited by 88
Self-citationSekine, H., Kinser, T. T. H., Qiao, F., Martinez, E., Paulling, E. E., Ruiz, P., Gilkeson, G. S., & Tomlinson, S. (2011) · Arthritis & Rheumatism · doi:10.1002/art.30222 · Cited by 87
Jacob, N., & Stohl, W. (2009) · Autoimmunity · doi:10.3109/08916930903374600 · Cited by 83
Aringer, M., Burkhardt, H., Burmester, G. R., Fischer‐Betz, R., Fleck, M., Graninger, W. B., Hiepe, F., Jacobi, A., Kötter, I., Lakomek, H. J., et al. (2011) · Lupus · doi:10.1177/0961203311426569 · Cited by 83
Flür, K., Allam, R., Zecher, D., Kulkarni, O. P., Lichtnekert, J., Schwarz, M., Beutler, B., Vielhauer, V., & Anders, H. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080585 · Cited by 82
Self-citationRyu, M., Migliorini, A., Miosge, N., Groß, O., Shankland, S. J., Brinkkoetter, P. T., Hagmann, H., Romagnani, P., Liapis, H., & Anders, H. (2012) · The Journal of Pathology · doi:10.1002/path.4046 · Cited by 82
Self-citationIntrarenal production of B-cell survival factors in human lupus nephritis
Neusser, M. A., Lindenmeyer, M. T., Edenhofer, I., Gaiser, S., Kretzler, M., Regele, H. M., Segerer, S., & Cohen, C. D. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.184 · Cited by 79
Hagele, H., Allam, R., Pawar, R. D., & Anders, H. (2009) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfp339 · Cited by 78
Self-citationTargeting the CXCR4/CXCL12 axis in systemic lupus erythematosus
Chong, B. F., & Mohan, C. (2009) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728220903196761 · Cited by 75
The Long Pentraxin Ptx3 Is Synthesized in IgA Glomerulonephritis and Activates Mesangial Cells
Bussolati, B., Peri, G., Salvidio, G., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.3.1466 · Cited by 71
A novel pathogenetic concept—antiviral immunity in lupus nephritis
Migliorini, A., & Anders, H. (2012) · Nature Reviews Nephrology · doi:10.1038/nrneph.2011.197 · Cited by 67
Self-citationKulkarni, O. P., Eulberg, D., Selve, N., Zöllner, S. K., Allam, R., Pawar, R. D., Pfeiffer, S., Segerer, S., Klußmann, S., & Anders, H. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.142711 · Cited by 67
Self-citationMjelle, J. E., Rekvig, O. P., van der Vlag, J., & Fenton, K. A. (2011) · Autoimmunity · doi:10.3109/08916934.2010.541170 · Cited by 66
Lack of SIGIRR/TIR8 aggravates hydrocarbon oil‐induced lupus nephritis
Lech, M., Skuginna, V., Kulkarni, O. P., Gong, J., Wei, T., Stark, R. W., Garlanda, C., Mantovani, A., & Anders, H. (2009) · The Journal of Pathology · doi:10.1002/path.2678 · Cited by 65
Self-citationIRF4 Deficiency Abrogates Lupus Nephritis Despite Enhancing Systemic Cytokine Production
Lech, M., Weidenbusch, M. J., Kulkarni, O. P., Ryu, M., Darisipudi, M. N., Susanti, H. E., Mittruecker, H., Mak, T. W., & Anders, H. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2010121260 · Cited by 63
Self-citationPseudoviral immunity – a novel concept for lupus
Anders, H. (2009) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2009.10.004 · Cited by 60
Self-citationViral RNA and DNA Trigger Common Antiviral Responses in Mesangial Cells
Allam, R., Lichtnekert, J., Moll, A. G., Taubitz, A., Vielhauer, V., & Anders, H. (2009) · Journal of the American Society of Nephrology · doi:10.1681/asn.2008101067 · Cited by 60
Self-citationHuck, S., Deveaud, E., Namane, A., & Zouali, M. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.11.1415 · Cited by 59
Kulkarni, O. P., Sayyed, S. G., Kantner, C., Ryu, M., Schnurr, M. M., Sárdy, M., Leban, J. J., Jankowsky, R., Ammendola, A., Doblhofer, R., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091227 · Cited by 56
Self-citationHägele, H., Allam, R., Pawar, R. D., Reichel, C. A., Krombach, F., & Anders, H. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.090182 · Cited by 54
Self-citationMdm2 Promotes Systemic Lupus Erythematosus and Lupus Nephritis
Allam, R., Sayyed, S. G., Kulkarni, O. P., Lichtnekert, J., & Anders, H. (2011) · Journal of the American Society of Nephrology · doi:10.1681/asn.2011010045 · Cited by 54
Self-citationKulkarni, O. P. (2008) · Frontiers in bioscience · doi:10.2741/2927 · Cited by 52
Fenton, K. A., Tømmerås, B., Marion, T. N., & Rekvig, O. P. (2009) · Autoimmunity · doi:10.3109/08916930903305633 · Cited by 52
Sekine, H., Ruiz, P., Gilkeson, G. S., & Tomlinson, S. (2011) · Molecular Immunology · doi:10.1016/j.molimm.2011.09.015 · Cited by 52
Lech, M., Römmele, C., Kulkarni, O. P., Susanti, H. E., Migliorini, A., Garlanda, C., Mantovani, A., & Anders, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020118 · Cited by 49
Self-citationApoptotic modifications affect the autoreactivity of the U1 snRNP autoantigen
Hof, D., Raats, J., & Pruijn, G. J. M. (2005) · Autoimmunity Reviews · doi:10.1016/j.autrev.2005.02.003 · Cited by 40
Hedberg, A., Fismen, S., Fenton, K. A., Fenton, C., Østerud, B., Mortensen, E., & Rekvig, O. P. (2010) · Arthritis & Rheumatism · doi:10.1002/art.30211 · Cited by 40
Thirty years of cyclophosphamide: assessing the evidence
Houssiau, F. (2007) · Lupus · doi:10.1177/0961203306075613 · Cited by 35
Abatacept for systemic lupus erythematosus: the outlook
Mok, C. C. (2012) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2012.721773 · Cited by 16
Cited by
Renal-Limited “Lupus-Like” Nephritis: How Much of a Lupus
Maziad, A. S. A., Torrealba, J., Seikaly, M. G., Hassler, J. R., & Hendricks, A. R. (2017) · Case Reports in Nephrology and Dialysis · doi:10.1159/000475493 · Cited by 1,299
Control of lupus nephritis by changes of gut microbiota
Mu, Q., Zhang, H., Liao, X., Lin, K., Liu, H., Edwards, M. R., Ahmed, S. A., Yuan, R., Li, L., Cecere, T. E., et al. (2017) · Microbiome · doi:10.1186/s40168-017-0300-8 · Cited by 404
NF-κB in inflammation and renal diseases
Zhang, H., & Sun, S.-C. (2015) · Cell & Bioscience · doi:10.1186/s13578-015-0056-4 · Cited by 383
“The pathogenesis of SLE and lupus nephritis involves both adaptive and innate immune cells, including T cells, B cells, dendritic cells and macrophages, as well as renal cells [59, 62, 64, 65].”
BackgroundGenetics and pathogenesis of systemic lupus erythematosus and lupus nephritis
Mohan, C., & Putterman, C. (2015) · Nature Reviews Nephrology · doi:10.1038/nrneph.2015.33 · Cited by 377
Redefining lupus nephritis: clinical implications of pathophysiologic subtypes
Yu, F., Haas, M., Glassock, R., & Zhao, M.-H. (2017) · Nature Reviews Nephrology · doi:10.1038/nrneph.2017.85 · Cited by 340
Metadata
- Authors
- Lech, M., & Anders, H.-J.
- Venue
- Journal of the American Society of Nephrology
- Published
- 2013-09
- Volume
- 24
- Issue
- 9
- Pages
- 1357-1366
- ISSN
- 1046-6673 (ISSN-L)
- OpenAlex
- W2119650820
- Cited by
- 496
- References
- 102
- FWCI
- 21.80
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.